Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38 NOK | +1.06% | -1.55% | -8.43% |
Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 * | 174M 16.33M | Sales 2025 * | 226M 21.14M | Capitalization | 586M 54.85M |
---|---|---|---|---|---|
Net income 2024 * | 7M 655K | Net income 2025 * | 13M 1.22M | EV / Sales 2024 * | 3 x |
Net cash position 2024 * | 63M 5.9M | Net cash position 2025 * | 65M 6.08M | EV / Sales 2025 * | 2.31 x |
P/E ratio 2024 * |
76.4
x | P/E ratio 2025 * |
43.3
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.85% |
Latest transcript on Gentian Diagnostics
1 day | +1.06% | ||
1 week | -1.55% | ||
Current month | -6.86% | ||
1 month | +5.56% | ||
3 months | -6.63% | ||
6 months | -4.76% | ||
Current year | -8.43% |
Managers | Title | Age | Since |
---|---|---|---|
Njaal Kind
CEO | Chief Executive Officer | 52 | 18-01-01 |
Hilja Ibert
CHM | Chairman | - | 18-07-15 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - | |
Kjersti Grimsrud
BRD | Director/Board Member | 63 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 38 | +1.06% | 1,960 |
24-05-15 | 37.6 | -0.53% | 11,905 |
24-05-14 | 37.8 | 0.00% | 23,376 |
24-05-13 | 37.8 | -2.07% | 6,812 |
24-05-10 | 38.6 | 0.00% | 4,356 |
Real-time Oslo Bors, May 16, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.43% | 54.76M | |
-4.67% | 12.33B | |
-5.19% | 8.14B | |
+28.74% | 5.62B | |
-8.09% | 4.24B | |
-54.79% | 3.06B | |
+13.49% | 2.76B | |
-1.34% | 2.41B | |
+33.20% | 2.23B | |
-3.55% | 1.87B |
- Stock Market
- Equities
- GENT Stock